Chenxiong Le

681 total citations
11 papers, 512 citations indexed

About

Chenxiong Le is a scholar working on Pathology and Forensic Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Chenxiong Le has authored 11 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Chenxiong Le's work include Colorectal Cancer Screening and Detection (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Gut microbiota and health (2 papers). Chenxiong Le is often cited by papers focused on Colorectal Cancer Screening and Detection (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Gut microbiota and health (2 papers). Chenxiong Le collaborates with scholars based in United States and Canada. Chenxiong Le's co-authors include Wendy I. White, Gabriel J. Robbie, Barbara White, Kathleen A. Cronin, Eric J. Feuer, Ruth M. Pfeiffer, Michael P. Fay, Yihong Yao, David S. Pearlman and Joseph M. Parker and has published in prestigious journals such as Biometrics, Annals of the Rheumatic Diseases and The Lancet Infectious Diseases.

In The Last Decade

Chenxiong Le

11 papers receiving 500 citations

Peers

Countries citing papers authored by Chenxiong Le

Since Specialization

Citations

This map shows the geographic impact of Chenxiong Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxiong Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxiong Le more than expected).

Fields of papers citing papers by Chenxiong Le

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenxiong Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxiong Le. The network helps show where Chenxiong Le may publish in the future.

Co-authorship network of co-authors of Chenxiong Le

This figure shows the co-authorship network connecting the top 25 collaborators of Chenxiong Le. A scholar is included among the top collaborators of Chenxiong Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenxiong Le. Chenxiong Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Title	Journal	Authors	Indexed citations
1	<p>Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone</p>	Infection and Drug Resistance	John F. Kokai‐Kun, Chenxiong Le et al.	15
2	Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial	The Lancet Infectious Diseases	John F. Kokai‐Kun, Tracey Roberts et al.	59
3	Selection of a cut-off for high- and low-methane producers using a spot-methane breath test: results from a large north American dataset of hydrogen, methane and carbon dioxide measurements in breath	Gastroenterology report	Klaus Gottlieb, Chenxiong Le et al.	21
4	Accurate Identification of Excessive Methane Gas Producers Is Possible by a Single Fasting Measurement of Methane: Analysis of a Large National Database Confirms Prior Results 2016 ACG Presidential Poster Award	The American Journal of Gastroenterology	Klaus Gottlieb, Stephen Carter et al.	1
5	A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients	Annals of the Rheumatic Diseases	Brandon W. Higgs, Wei Zhu et al.	131
6	Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma	BMC Pulmonary Medicine	Joseph M. Parker, Chad K. Oh et al.	110
7	A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis	Journal of the American Academy of Dermatology	Robert Bissonnette, Kim Papp et al.	63
8	Age‐conditional probabilities of developing cancer	Statistics in Medicine	Michael P. Fay, Ruth M. Pfeiffer et al.	91
9	Significance of Epidermoid Formations in the Middle Ear in Fetuses and Children	Archives of Otolaryngology - Head and Neck Surgery	Fatma Tülin Kayhan, Cemil Mutlu et al.	13
10	Treatment Evaluation in Otitis Media Research	Archives of Otolaryngology - Head and Neck Surgery	Chenxiong Le, Bruce R. Lindgren et al.	3
11	Association between Survival Time and Ordinal Covariates	Biometrics	Chenxiong Le, Patricia M. Grambsch et al.	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact